GRI Bio Inc (GRI)

GRI Bio Inc has recorded no insider trading activity within the past ninety days. The most recent transactions occurred in June 2021, when the Chief Financial Officer acquired shares through multiple purchases. Prior to that, the Chief Executive Officer also bought stock in February 2021.
Ticker: GRI Exchange: NAS


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for GRI Bio Inc. Upgrade to see score, net flow, insiders and the full signal context.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.7
Kelly Leanne M. Chief Financial Officer Officer
Transaction date
Purchase
Price
193.11
Quantity 2,907 +7.6%
Value US$925,057
3.7
Kelly Leanne M. Chief Financial Officer Officer
Transaction date
Purchase
Price
480.54
Quantity 9,840 -19.9%
Value US$4,554,210
3.7
Kelly Leanne M. Chief Financial Officer Officer
Transaction date
Purchase
Price
253.89
Quantity 14,590 -22.7%
Value US$4,524,590
0.5
Baker David Charles Chief Executive Officer Executive Director
Transaction date
Purchase
Price
8.00
Quantity 1,000 +12.8%
Value US$8,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2021-06-04 2021-06-04 B Purchase

Chief Financial Officer

Officer
2,907 +7.6%
193.11
US$925,057
2,907 +7.6% 193.11 US$925,057
2021-06-04 2021-06-03 B Purchase

Chief Financial Officer

Officer
9,840 -19.9%
480.54
US$4,554,210
9,840 -19.9% 480.54 US$4,554,210
2021-06-04 2021-06-02 B Purchase

Chief Financial Officer

Officer
14,590 -22.7%
253.89
US$4,524,590
14,590 -22.7% 253.89 US$4,524,590
2021-02-12 2021-02-12 B Purchase

Chief Executive Officer

Executive Director
1,000 +12.8%
8.00
US$8,000
1,000 +12.8% 8.00 US$8,000